Findings from the largest study to evaluate sex differences in HIV-related cognitive dysfunction.
This study may help alleviate doubts about whether laypersons can perform the test and interpret the results correctly on their own.
Results of this study suggest a combined epidemic of sexual ill-health, drug use harms, and mental illness among HIV-positive MSM who engage in slamsex and chemsex.
PrEP can decrease risk of HIV transmission. It can also contribute to risky sexual behavior and STIs.
The population of children who had prenatal exposure to HIV and to antiretroviral agents who do not become infected with HIV is growing. What effect do ARVs have on neurodevelopment in this group?
Clinical trials of second generation direct-acting antivirals in HCV show high cure rates. But do those rates reflect real life?
This case study of 2 patients suggests that very early antiretroviral therapy is not enough to prevent formation of latent viral reservoirs and prevent HIV rebound on treatment discontinuation.
A systematic approach may help more primary care clinicians identify men who have sex with men among their patients, which in turn could help them focus on patients in need of more frequent HIV testing and preventive services.
"What we need to do now is to help people with HIV realize the full potential of their much-extended life expectancy."
Why has the HIV epidemic shifted from affluent gay white men in New York and San Francisco to impoverished people of color in the South?
While a few studies have suggested that HAART therapy is generally cardioprotective, the long-term impact of prenatal and postnatal exposure on cardiac structure and function has remained unknown. A new study sheds light.
It’s how much cannabis your patients with HIV infection smoke now—not over their lifetime—that appears to affect their cognition.
Eleven new drugs for HIV representing 5 new categories of mechanism of action are now in various phases of clinical trials. Here's an overview.